Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands

[cafead]

via

• Novo Nordisk reported strong data for its next-gen anti-obesity medicine.
• The Danish company has an excellent weight loss drug pipeline.
• But it's also diversifying its lineup and offering other perks.

article source